Recent Quotes
My Watchlist
Indicators
Local Stocks
NewsOK Local Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Gw Pharma ADR (NQ: GWPH )

215.30 USD +0.45 (+0.21%)
Streaming Delayed Price Updated: 11:34 AM EST, Feb 26, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Gw Pharma ADR

< Previous 1 2 3 4 5 6 7 8 9
...
25 26 Next >
Public Acceptance Fuels Growth of CBD and Support Industries
Tags NNW News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
CannabisNewsAudio – Lexaria Bioscience Corp.’s (CSE: LXX) (OTC: LXRP) Distinctive Intellectual Property Drives Success
From CannabisNewsWire
GW Pharmaceuticals plc Announces the Closing of Public Offering of ADSs, Raising Gross Proceeds of $345 Million and Full Exercise of Underwriters' Option to Purchase Additional ADSs
GW Pharmaceuticals plc (Nasdaq: GWPH, "GW," and the “Company”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid... 
From GlobeNewswire News Releases
Intangible Assets Power Growth, Acquisitions in the Pharmaceuticals Sector
From CannabisNewsWire
Intangible Assets Power Growth, Acquisitions in the Pharmaceuticals Sector
Tags LXRP News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Intangible Assets Power Growth, Acquisitions in the Pharmaceuticals Sector
From PR Newswire
Intangible Assets Power Growth, Acquisitions in the Pharmaceuticals Sector
Tags NNW News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
GW Pharmaceuticals plc Announces Pricing of Public Offering of ADSs Raising Gross Proceeds of $300 Million
GW Pharmaceuticals plc (Nasdaq: GWPH, "GW," and the “Company”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid... 
From GlobeNewswire News Releases
CannabisNewsAudio – Youngevity International, Inc. (NASDAQ: YGYI) Utilizes Market Experience to Enter CBD Supplement Market
From CannabisNewsWire
GW Pharmaceuticals Announces Proposed Public Offering of ADSs
GW Pharmaceuticals plc (Nasdaq: GWPH, “GW,” “the Company” or “the Group”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary... 
From GlobeNewswire News Releases
The Most Exciting Story In The $140 Billion Cannabis Boom
FN Media Group Presents Safehaven.com Market Commentary 
From PR Newswire
GW Pharmaceuticals plc and its U.S. Subsidiary Greenwich Biosciences Announce the DEA has Rescheduled EPIDIOLEX® (cannabidiol) Oral Solution to Schedule V
Product expected to be available within six weeks 
From GlobeNewswire News Releases
CBD Supplements Primed to Explode Ahead of Biopharma as Farm Bill Legalizes Hemp
From CannabisNewsWire
CBD Supplements Primed to Explode Ahead of Biopharma as Farm Bill Legalizes Hemp
From PR Newswire
Data Projects the U.S. Medical Cannabis Market to Reach USD 12.5 Billion by 2025
FinancialBuzz.com News Commentary 
From PR Newswire
United States to Issue Additional Cannabis Growing Licenses for Research Purposes
FinancialBuzz.com News Commentary 
From PR Newswire
CannabisNewsAudio – Youngevity International, Inc. (NASDAQ: YGYI) Exploits Growing Popularity of Cannabidiol
From CannabisNewsWire
Cannabidiol (CBD) Infusion into Healthcare Products Industry Growing Faster Than Expected
From PR Newswire
Cannabidiol (CBD) Infusion into Healthcare Products Industry Growing Faster Than Expected
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
CBD Contributes to Continued Growth for Nutraceutical, Pharmaceutical and Cannabis Key Players
From CannabisNewsWire
CBD Contributes to Continued Growth for Nutraceutical, Pharmaceutical and Cannabis Key Players
From PR Newswire
Global Cannabis Market Set to Expand as Investment Traffic Increases
FinancialBuzz.com News Commentary 
From PR Newswire
Data Shows Medical Cannabis Could Reach USD 19 Billion in Sales by 2027
FinancialBuzz.com News Commentary 
From PR Newswire
Cannabis Retail Sales Continue to Grow as Legalization Spreads
FinancialBuzz.com News Commentary 
From PR Newswire
Big Businesses Look for Healthier Alternatives to Smoking for Drug Delivery
From PR Newswire
Advancements in Cultivation Technology Boost the Legal Cannabis Market
FinancialBuzz.com News Commentary 
From PR Newswire
GW Pharmaceuticals plc Reports Fiscal Third Quarter 2018 Financial Results and Operational Progress
GW Pharmaceuticals plc (NASDAQ: GWPH, GW, the Company or the Group), the world leader in the development and commercialization of cannabinoid prescription medicines, announces financial results for the... 
From GlobeNewswire News Releases
Medicinal Cannabis Market Expected to Grow to Nearly $20 Billion by 2024
From PR Newswire
Lexaria’s DehydraTECH Triples Bioavailability of CBD in Human Trial -- CFN Media
CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, today announced publication of an article covering Lexaria Bioscience... 
From GlobeNewswire News Releases
Lexaria's DehydraTECH Triples Bioavailability of CBD in Human Trial -- CFN Media
From NewMediaWire
< Previous 1 2 3 4 5 6 7 8 9
...
25 26 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.